Low Utilization of Beta-Blockers Among Medicare Beneficiaries Hospitalized for Heart Failure With Reduced Ejection Fraction.

ABSTRACT:

Background

The evidence-based beta-blockers carvedilol, bisoprolol, and metoprolol succinate reduce mortality and hospitalizations among patients with heart failure with reduced ejection fraction (HFrEF). Use of these medications is not well described in the general population of patients with HFrEF, especially among patients with potential contraindications.

Objectives

Our goal was to describe the patterns of prescription fills for carvedilol, bisoprolol, and metoprolol succinate among Medicare beneficiaries hospitalized for HFrEF, as well as to estimate the associations between specific contraindications for beta-blocker therapy and those patterns.

Methods and results

With the use of the cohort of 15,205 Medicare beneficiaries hospitalized for HFrEF from 2007 to 201

SUBMITTER: Loop MS 

PROVIDER: S-EPMC6467695 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature